INCIDENCE OF ACUTE EXUDATIVE MACULOPATHY AFTER REDUCED-FLUENCE PHOTODYNAMIC THERAPY
Authors:
- Farzin ForooghianFFFarzin Forooghian
- 1 January 2017
- journal article
- case report
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 11 (3) , 217-220
Abstract
Purpose: To describe the incidence and features of acute exudative maculopathy (AEM) after half-fluence photodynamic therapy (PDT) and/or very minimal fluence PDT. Methods: Retrospective chart review of all patients treated over a 7-year period. Results: A total of 52 patients (58 eyes, 140 treatments) were treated with half-fluence PDT and/or very minimal fluence PDT. Patients were diagnosed with either central serous chorioretinopathy (CSCR) or neovascular age-related macular degeneration (nAMD). Two patients (1 CSCR and 1 nAMD) returned to the clinic with acute vision loss after treatment and were identified as having developed AEM. In the CSCR case, resolution occurred after intravitreal bevacizumab treatment. The nAMD case resolved with topical difluprednate treatment. We were unable to identify any risk factors for the development of AEM. Conclusion: AEM seems to be a rare (incidence 1.4% per treatment) and unpredictable reaction related to the proinflammatory effects of half-fluence PDT and very minimal fluence PDT. Because of the inherent limitations of this study, the true incidence of AEM after reduced-fluence PDT may be higher.Keywords
This publication has 10 references indexed in Scilit:
- Photodynamic therapy: current role in the treatment of chorioretinal conditionsEye, 2016
- Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathyBMC Ophthalmology, 2014
- HALF-FLUENCE PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2013
- Very minimal fluence photodynamic therapy for chronic central serous chorioretinopathyCanadian Journal of Ophthalmology, 2012
- COMPARISON OF EFFICACY AND SAFETY BETWEEN HALF-FLUENCE AND FULL-FLUENCE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2011
- Acute Severe Visual Decrease After Photodynamic Therapy with Verteporfin: Spectral-Domain OCT FeaturesOphthalmic Surgery, Lasers and Imaging Retina, 2010
- INFLUENCE OF VERTEPORFIN PHOTODYNAMIC THERAPY ON INFLAMMATION IN HUMAN CHOROIDAL NEOVASCULAR MEMBRANES SECONDARY TO AGE-RELATED MACULAR DEGENERATIONRetina, 2007
- Influence of Treatment Parameters on Selectivity of Verteporfin TherapyInvestigative Ophthalmology & Visual Science, 2006
- Optical coherence tomography findings following photodynamic therapy of choroidal neovascularizationAmerican Journal of Ophthalmology, 2002
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999